Fact CheckerSign in

NCT06519318Completed

Validity And Reliability of The Incremental Shuttle Walk Test In Type 2 Diabetes Mellitus

Validity And Reliability of The Incremental Shuttle Walk Test In Individuals With Type 2 Diabetes Mellitus

Source: ClinicalTrials.gov · Last updated 4 Dec 2025

Brief summary (registry, in English)

The aim of our study was to determine the validity and reliability of the incremental shuttle walk test (ISWT) in patients with type 2 diabetes mellitus.This study involves the evaluation of the validity and test-retest reliability of the ISWT. The assessments will be performed in two separate time periods. At the first visit, baseline assessments of the patient will be performed. These assessments include the recording of demographic information and the ISWT and 6 minute walk test assessments. Both tests will be performed with a 30-minute interval between them. A retest will be performed 1 week after the initial assessment.

Status (registry)
Completed
Study type
Observational
Enrollment
120 (actual)
First submitted
19 Jul 2024
Start date
30 Mar 2025
Primary completion date
30 Jul 2025
Lead sponsor
Ilayda Kayapinar
NCT number
NCT06519318

What you commit to

  • Study type: Observational
  • Participants enrolled: 120
  • From 30 Mar 2025 to the primary completion date, 30 Jul 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Uncontrolled diabetes,
  • Patients with uncontrolled hypotension or hypertension
  • Unstable cardiovascular and pulmonary conditions
  • Having vertigo and various vestibular system disorders
  • Those with severe neurological or severe respiratory diseases

Other

  • Lack of co-operation
  • Patients with major musculoskeletal problems
  • Pregnant women

Who the study is looking for

  • HbA1c between 6.5 and 11
  • No mental problems
  • Able to walk independently

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Bezmialem Foundation University Hospital
Coordinator of this site? Confirm its status
IstanbulTurkey (Türkiye)Unknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.